Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,337
datasets available to search
ShareScore release 0.9.0
Dataset results
1,337 results for “inflammatory disease”
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
ClinicalTrials.gov study NCT01160640. IPD Sharing: NO. Countries: 1. Publications: 1.
Bacteriotherapy in Pediatric Inflammatory Bowel Disease
ClinicalTrials.gov study NCT01757964. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease
ClinicalTrials.gov study NCT02539368. IPD Sharing: NO. Countries: 13. Publications: 1.
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
ClinicalTrials.gov study NCT01692743. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
ClinicalTrials.gov study NCT00069329. IPD Sharing: YES. Countries: 1. Publications: 8.
ADOAIR250 Anti-inflammatory Effects in Japanese Subjects With Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov study NCT01607398. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients
ClinicalTrials.gov study NCT02461758. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Learn How Well Nifurtimox Works and How Safe it is in Children Aged 0 to 17 Years With Chagas' Disease, an Inflammatory, Infectious Disease Caused by the Parasite Trypanosoma Cruzi
ClinicalTrials.gov study NCT02625974. IPD Sharing: Not stated. Countries: 3. Publications: 5.
Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases
ClinicalTrials.gov study NCT01560819. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Data from: The common TMEM173 HAQ, AQ alleles rescue CD4 T cellpenia, restore T-regs, and prevent SAVI (N153S) inflammatory disease in mice
Open the record for dataset details and reuse information.
Strategic delivery of Omega-3 fatty acids for modulating inflammatory neurodegenerative diseases
Open the record for dataset details and reuse information.
Data from: Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer's disease mortality
Alzheimer disease (AD) mortality risk in a large cohort of subjects treated or not with non-steroidal anti-inflammatory drugs (NSAIDs) is unknown. Our objective was to determine whether NSAIDs use is associated with decreased risk of AD mortality. Methods: In this prospective, population-based study (Neurological Disorders in Central Spain [NEDICES]) of 5,072 people without AD (aged 65 years and older), sociodemographic, comorbidity factors, and current medications were recorded at baseline. Community-dwelling older adults were followed for a median of 12.7 years, after which the death certificates of deceased participants were examined. 2,672 (52.7%) of 5,072 participants died, including 504 (18.9%) NSAIDs users and 2,168 (81.1%) non-users. Of the 2,672 deceased participants, 113 (4.2%) had AD as a cause of death (8 [1.6%] among NSAIDs users and 105 [4.8%] among non-users, chi-square = 10.70, p=0.001). In an unadjusted Cox model, risk of AD mortality was decreased in NSAIDs users (hazard ratio [HR] for AD mortality = 0.35, 95% confidence interval [CI] 0.17–0.72, p=0.004) when compared to non-users. After adjusting for numerous demographic factors and co-morbidities, the HR for AD mortality in NSAIDs users was 0.29, 95% CI 0.12–0.73, p=0.009. Stratified analyses showed a significantly decreased risk of AD mortality with aspirin, whereas non-aspirin NSAIDs only showed a statistical trend toward significance in the adjusted Cox regression models. NSAIDs use was associated with 71% decreased risk of AD mortality in older adults. Our results support the hypothesis that NSAIDs use is a protective factor of developing AD.
DATA of Effect of different iterative reconstruction algorithms on ultra-low dose CT of inflammatory bowel disease in a rabbit model
<p>This file contains the experimental data of the scientific paper titled: " <strong>Effect of different iterative reconstruction algorithms on ultra-low dose CT of inflammatory bowel disease in a rabbit model"</strong></p>
RNA-seq Data for Bacteroides fragilis Toxin Suppresses METTL3-Mediated m6A Modification in Macrophage to Promote Inflammatory Bowel Disease
Open the record for dataset details and reuse information.
Biohybrid microrobots regulate colonic cytokine and epithelium barrier in inflammatory bowel disease
<p>Cytokines have been identified as key contributors to the development of inflammatory bowel disease (IBD), yet conventional treatments often prove inadequate and carry substantial side effects. Here, we show an innovative biohybrid robotic system, termed 'algae-MΦNP-robot', for addressing IBD by actively neutralizing colonic cytokine levels. Our approach combines moving green microalgae with macrophage membrane-coated nanoparticles (MΦNPs) to efficiently capture pro-inflammatory cytokines 'on-the-fly'. The dynamic algae-MΦNP-robots outperform static counterparts by enhancing cytokine removal through continuous movement, better distribution, and extended retention in the colon. This system is encapsulated within an oral capsule, which shields it from gastric acidity and ensures functionality upon reaching the targeted disease site. The resulting algae-MΦNP-robot capsule effectively regulates cytokine levels, facilitating the healing of damaged epithelial barriers. It shows markedly improved prevention and treatment efficacy in a mouse model of IBD and demonstrates an excellent biosafety profile. Overall, our biohybrid algae-MΦNP-robot system offers a promising and efficient solution for IBD, addressing cytokine-related inflammation effectively.</p>
Understanding the Rare Inflammatory Disease Using Large Language Models and Social Media Data
Open the record for dataset details and reuse information.
Inflammatory bowel disease drug approval color diagram
<p>Inflammatory bowel disease colorful diagram on drug use</p>
Inflammatory bowel disease and immune-mediated inflammatory diseases (IMID) therapy
<p>Immune-mediated inflammatory diseases (IMID) and inflammatory bowel diseases share therapeutic targets and approval drugs. This table tries to summarize shared therapeutic approval drugs</p> <p>Additional information can be found at www.ibd-eii.com</p>
Inflammatory bowel disease and extra intestinal manifestations therapy
<p>Inflammatory bowel disease often present with associated extra intestinal manifestations, here you can find proved therapies that are known to have an impact on extra intestinal manifestation course.</p> <p>Additional information can be found at www.ibd-eii.com</p>
Data from: Lupus and inflammatory bowel disease share a common set of microbiome features distinct from other autoimmune disorders
<p>Supplemental data for "Lupus and inflammatory bowel disease share a common set of microbiome features distinct from other autoimmune disorders"</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.